Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Receivables (2021 - 2025)

Pulse Biosciences (PLSE) has 3 years of Receivables data on record, last reported at $274000.0 in Q4 2025.

  • For Q4 2025, Receivables changed N/A year-over-year to $274000.0; the TTM value through Dec 2025 reached $274000.0, changed N/A, while the annual FY2025 figure was $274000.0, N/A changed from the prior year.
  • Receivables reached $274000.0 in Q4 2025 per PLSE's latest filing, up from $15000.0 in the prior quarter.
  • Across five years, Receivables topped out at $274000.0 in Q4 2025 and bottomed at $5000.0 in Q3 2022.
  • Average Receivables over 3 years is $65142.9, with a median of $21000.0 recorded in 2022.
  • The widest YoY moves for Receivables: up 93.06% in 2022, down 93.06% in 2022.
  • A 3-year view of Receivables shows it stood at $61000.0 in 2021, then tumbled by 91.8% to $5000.0 in 2022, then skyrocketed by 5380.0% to $274000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $274000.0 in Q4 2025, $15000.0 in Q3 2025, and $5000.0 in Q3 2022.